Major Ingredients

Meropenem USP 500mg injection.

Major Functionality

Meropenem IV is indicated for the treatment, in adults and children, of the following infections caused by single or multiple bacteria sensitive to Meropenem. These are as follows: Pneumonias and nosocomial pneumonias, Urinary tract infections, Intra-abdominal infections, Gynaecological Infections, such as endometritis Skin and Skin structure infections, Meningitis, septicaemia, Empiric treatment, including monotherapy, for presumed infections in adult patient with febrile neutropenia.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.